Allergan logo

AGN - Allergan Share Price

$193.02 0.0  0.0%

Last Trade - 08/05/20

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £11.63bn
Position in Universe th / 6651
Bullish
Bearish
Unlock AGN Revenue
Momentum
Relative Strength (%)
1m +9.51%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
4,677 12,688 14,571 15,941 15,787 16,089 15,698 16,268 +28.0%
+8.13
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 March 2020, Allerganplc revenues remained flat at $3.6B. Net income totaled$378M vs. loss of $2.41B. Revenues reflect US GeneralMedicine segment increase of 5% to $1.31B, Other segmentincrease from $2.8M to $51M, also reflect Internationalsegment decrease of 13% to $690M, Nephrology segmentdecrease of 87% to $1.4M. Net income reflects Goodwillimpairments decrease of 63% to $913M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AGN Revenue Unlock AGN Revenue

Net Income

AGN Net Income Unlock AGN Revenue

Normalised EPS

AGN Normalised EPS Unlock AGN Revenue

PE Ratio Range

AGN PE Ratio Range Unlock AGN Revenue

Dividend Yield Range

AGN Dividend Yield Range Unlock AGN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AGN EPS Forecasts Unlock AGN Revenue
Profile Summary

Allergan plc is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter pharmaceutical products. The Company operates through three segments: US Specialized Therapeutics, US General Medicine and International. The US Specialized Therapeutics segment includes sales relating to branded products within the United States, including Medical Aesthetics, Medical Dermatology, Eye Care, Neurosciences and Urology therapeutic products. The US General Medicine segment includes sales relating to branded products within the United States that do not fall into the US Specialized Therapeutics business units, including Central Nervous System, Gastrointestinal, Women's Health, Anti-Infectives and Diversified Brands. The International segment includes sales relating to products sold outside the United States.

Directors
Last Annual December 31st, 2019
Last Interim March 31st, 2020
Incorporated May 16, 2013
Public Since October 1, 2013
No. of Shareholders: 2,977
No. of Employees: 17,400
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange New York Stock Exchange
Shares in Issue 329,805,791
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AGN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AGN
Upcoming Events for AGN
Frequently Asked Questions for Allergan
What is the Allergan share price?

As of 08/05/20, shares in Allergan are trading at $193.02, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Allergan share price performed this year?

Shares in Allergan are currently trading at $193.02 and the price has moved by 37.62% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Allergan price has moved by 8.54% over the past year.

What are the analyst and broker recommendations for Allergan?

Of the analysts with advisory recommendations for Allergan, there are there are currently 0 "buy" , 15 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Allergan is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Allergan next release its financial results?

Allergan is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Allergan dividend yield?

The Allergan dividend yield is % based on the trailing twelve month period.

Does Allergan pay a dividend?

Last year, Allergan paid a total dividend of 2.96, and it currently has a trailing dividend yield of %. Looking ahead, Allergan has not announced an ex-dividend date yet.

When does Allergan next pay dividends?

Allergan has yet to annouce their ex-dividend date. The historic dividend yield on Allergan shares is currently %.

How do I buy Allergan shares?

To buy shares in Allergan you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Allergan?

Shares in Allergan are currently trading at $193.02, giving the company a market capitalisation of £n/a.

Where are Allergan shares listed? Where are Allergan shares listed?

Here are the trading details for Allergan:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: AGN
What kind of share is Allergan?

We were not able to load our ranking data for Allergan

Is there a Allergan share price forecast 2021?

We were not able to load any forecast data for Allergan.

How can I tell whether the Allergan share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Allergan. Over the past six months, the relative strength of its shares against the market has been -5.86%. At the current price of $193.02, shares in Allergan are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Allergan PE Ratio?

We were not able to find PE ratio data for Allergan.

Who are the key directors of Allergan?

We were unable to find the directors for Allergan.

Who are the major shareholders of Allergan?

Here are the top five shareholders of Allergan based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 7.59% (25.0m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 4.45% (14.7m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 4.26% (14.1m shares)
Adage Capital Management, L.P. Hedge Fund
Percentage owned: 3.17% (10.5m shares)
Credit Suisse Securities (USA) LLC Research Firm
Percentage owned: 3.09% (10.2m shares)
Similar to AGN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.